Moore DM - Search Results

1

Including Online-Recruited Seeds: A Respondent-Driven Sample of Men Who Have Sex With Men.

Lachowsky NJ, Lal A, Forrest JI, Card KG, Cui Z, Sereda P, Rich A, Raymond HF, Roth EA, Moore DM, Hogg RS. Lachowsky NJ, et al. Among authors: moore dm. J Med Internet Res. 2016 Mar 15;18(3):e51. doi: 10.2196/jmir.5258. J Med Internet Res. 2016. PMID: 26980147 Free PMC article.

2

Trends in antenatal human immunodeficiency virus prevalence in Western Kenya and Eastern Uganda: evidence of differences in health policies?

Moore DM, Hogg RS. Moore DM, et al. Int J Epidemiol. 2004 Jun;33(3):542-8. doi: 10.1093/ije/dyh127. Epub 2004 Mar 24. Int J Epidemiol. 2004. PMID: 15044420

3

Discordant immunologic and virologic responses to highly active antiretroviral therapy are associated with increased mortality and poor adherence to therapy.

Moore DM, Hogg RS, Yip B, Wood E, Tyndall M, Braitstein P, Montaner JS. Moore DM, et al. J Acquir Immune Defic Syndr. 2005 Nov 1;40(3):288-93. doi: 10.1097/01.qai.0000182847.38098.d1. J Acquir Immune Defic Syndr. 2005. PMID: 16249702 Clinical Trial.

4

Disease progression in patients with virological suppression in response to HAART is associated with the degree of immunological response.

Moore DM, Hogg RS, Chan K, Tyndall M, Yip B, Montaner JS. Moore DM, et al. AIDS. 2006 Feb 14;20(3):371-7. doi: 10.1097/01.aids.0000196180.11293.9a. AIDS. 2006. PMID: 16439870

5

Risks of non-accidental mortality by baseline CD4+ T-cell strata in hepatitis-C-positive and -negative individuals initiating highly active antiretroviral therapy.

Moore DM, Hogg RS, Braitstein P, Wood E, Yip B, Montaner JS. Moore DM, et al. Antivir Ther. 2006;11(1):125-9. Antivir Ther. 2006. PMID: 16518968

6

Performance of immunologic responses in predicting viral load suppression: implications for monitoring patients in resource-limited settings.

Moore DM, Mermin J, Awor A, Yip B, Hogg RS, Montaner JS. Moore DM, et al. J Acquir Immune Defic Syndr. 2006 Dec 1;43(4):436-9. doi: 10.1097/01.qai.0000243105.80393.42. J Acquir Immune Defic Syndr. 2006. PMID: 17019367

7

Determining eligibility for antiretroviral therapy in resource-limited settings using total lymphocyte counts, hemoglobin and body mass index.

Moore DM, Awor A, Downing RS, Were W, Solberg P, Tu D, Chan K, Hogg RS, Mermin J. Moore DM, et al. AIDS Res Ther. 2007 Jan 18;4:1. doi: 10.1186/1742-6405-4-1. AIDS Res Ther. 2007. PMID: 17233896 Free PMC article.

8

Differential impact of adherence on long-term treatment response among naive HIV-infected individuals.

Lima VD, Harrigan R, Murray M, Moore DM, Wood E, Hogg RS, Montaner JS. Lima VD, et al. Among authors: moore dm. AIDS. 2008 Nov 12;22(17):2371-80. doi: 10.1097/QAD.0b013e328315cdd3. AIDS. 2008. PMID: 18981777

9

Reduction of HIV incidence in men who have sex with men.

Hogg RS, Moore DM, Michelow WD, Montaner JS. Hogg RS, et al. Among authors: moore dm. Lancet Infect Dis. 2010 Oct;10(10):655-6. doi: 10.1016/S1473-3099(10)70200-0. Epub 2010 Sep 9. Lancet Infect Dis. 2010. PMID: 20832365 No abstract available.

10

Home is where the HAART is: an examination of factors affecting neighbourhood perceptions among people with HIV/AIDS on antiretroviral therapy.

Vasarhelyi K, Brandson EK, Palmer AK, Fernandes KA, Zhang W, Moore DM, Montaner JS, Hogg RS. Vasarhelyi K, et al. Among authors: moore dm. AIDS Care. 2011 Feb;23(2):245-51. doi: 10.1080/09540121.2010.490256. AIDS Care. 2011. PMID: 21259138

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

314 results

Search Page

Filters